GI Dynamics (ASX:GID) announced that CEO & president Scott Schorer has departed and that Joseph Virgilio is assuming both roles. Virgilio, previously the company’s COO, took over as president & CEO on Nov. 2, with no changes made to his current compensation as of yet. GI Dynamics confirmed in a news release that Virgilio’s current executive […]
Diabetes
Tandem Diabetes slides after hours on mixed bag Q3
Tandem Diabetes Care (NSDQ:TNDM) shares took a hit after hours today on third-quarter results that were mixed compared to the consensus forecast. The San Diego-based insulin delivery and diabetes technology company posted losses of -$9.4 million, or -15¢ per share, on sales of $123.6 million for the three months ended Sept. 30, 2020, for a bottom-line […]
LifeScan names new chief marketing officer
LifeScan today said it appointed Lisa Rose as chief marketing officer, effective immediately. Prior to joining the company, Rose was the chief marketing and innovation officer of Vyaire Medical. She was responsible for growing the company’s respiratory business with new products while leading the marketing, business development, R&D, regulatory affairs and medical affairs organizations. She […]
Insulet surpasses Q3 earnings estimates, raises guidance
Insulet (NSDQ:PODD) posted third-quarter results after market close yesterday that beat analysts’ consensus for the company. The Acton, Mass.-based tubeless insulin pump manufacturer announced profits of $11.6 million or $0.17 per share on sales of $234 million for the three months ended September 30, 2020, for a bottom-line gain of 13.5% on sales growth of 21% […]
Dexcom down big despite strong Q3, raised guidance
Dexcom (NSDQ:DXCM) shares took a big hit today on third-quarter results that trounced the consensus forecast. Shares of DXCM were down nearly -9% at $346.51 per share in mid-morning trading today. The San Diego-based insulin delivery technology developer posted profits of $72.2 million, or 73¢ per share, on sales of $500.9 million for the three months […]
Abbott beats the Street in Q3, projects higher full-year sales
Abbott (NYSE:ABT) posted stronger-than-expected third-quarter earnings today and upped its full-year projections. The Abbott Park, Ill.-based healthcare giant reported profits of $1.232 billion or 98¢ per share for the quarter ended Sept. 30, 2020, led by a whopping 38.2% increase in global diagnostics sales and a 27% sales jump for diabetes care devices. Analysts had projected […]
CB Insights reports digital health, global healthcare investment funding records
CB Insights reported record funding for global healthcare and digital health, among other milestones during the third quarter. Global healthcare investments to private companies hit a new quarterly record of $21.8 billion in the third quarter of this year, with a total of 1,539 equity investments in the three-month period growing 18% from the previous […]
Medtronic CEO Geoff Martha: ‘Time to be bold and add grit’
Medtronic (NYSE:MDT) CEO Geoff Martha has no intention of slowing the medtech giant down amid the COVID-19 pandemic. Speaking during the Fridley, Minn.-based company’s “Investor Day” virtual presentation, Martha made one thing clear: “We are going on the offensive,” Martha said at the start and echoed throughout the program. About six months into his tenure as […]
Dexcom, Lilly partner on diabetes management for healthcare providers
Eli Lilly (NYSE:LLY) and Dexcom (NSDQ:DXCM) today announced a joint program for U.S. healthcare providers that includes Lilly’s new, rapid-acting Lyumjev mealtime insulin pen and Dexcom G6 continuous glucose monitoring (CGM) systems. The program is designed to help clinicians use data to inform diabetes management, including promoting the benefits of a new mealtime insulin dose, the companies said […]
Stryker launches nailing system to treat foot conditions
Stryker (NYSE:SYK) announed today that it has launched its T2 ICF intramedullary nailing system. The new system is meant to help people suffering from serious foot conditions including Charcot foot, which can arise among poeple with diabetes and cause poor bone quality and potential nerve damage and foot ulcers. Stryker describes the T2 ICF system as […]
Abbott’s FreeStyle Libre 3 receives CE Mark
Abbott (NYSE:ABT) has won the CE Mark in the European Union for its next-generation FreeStyle Libre 3 continuous glucose monitoring system. Officials at Abbott boast that the Libre 3 technology includes a super small, thin sensor. It’s the size of two U.S. pennies stacked together and able to accurately provide real-time glucose readings over 14 days […]
